- Home
- TECH vs CDE Comparison
TECH vs CDE Comparison
Compare TECH & CDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- CDE
- Stock Information
- Founded
- TECH 1976
- CDE 1928
- Country
- TECH United States
- CDE United States
- Employees
- TECH N/A
- CDE N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- CDE Precious Metals
- Sector
- TECH Health Care
- CDE Basic Materials
- Exchange
- TECH Nasdaq
- CDE Nasdaq
- Market Cap
- TECH 8.9B
- CDE 9.5B
- IPO Year
- TECH 1989
- CDE N/A
- Fundamental
- Price
- TECH $64.75
- CDE $16.12
- Analyst Decision
- TECH Strong Buy
- CDE Strong Buy
- Analyst Count
- TECH 14
- CDE 3
- Target Price
- TECH $71.23
- CDE $16.33
- AVG Volume (30 Days)
- TECH 2.1M
- CDE 19.2M
- Earning Date
- TECH 11-05-2025
- CDE 10-29-2025
- Dividend Yield
- TECH 0.50%
- CDE N/A
- EPS Growth
- TECH N/A
- CDE N/A
- EPS
- TECH 0.49
- CDE 0.74
- Revenue
- TECH $1,216,732,000.00
- CDE $1,700,723,000.00
- Revenue This Year
- TECH $3.64
- CDE $92.88
- Revenue Next Year
- TECH $7.59
- CDE $15.59
- P/E Ratio
- TECH $132.78
- CDE $21.94
- Revenue Growth
- TECH 3.85
- CDE 68.28
- 52 Week Low
- TECH $46.01
- CDE $4.58
- 52 Week High
- TECH $79.28
- CDE $23.62
- Technical
- Relative Strength Index (RSI)
- TECH 62.28
- CDE 52.42
- Support Level
- TECH $57.02
- CDE $13.55
- Resistance Level
- TECH $66.06
- CDE $15.17
- Average True Range (ATR)
- TECH 2.06
- CDE 0.85
- MACD
- TECH 0.56
- CDE 0.18
- Stochastic Oscillator
- TECH 86.04
- CDE 99.42
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.